Mood and Anxiety Disorders During Pregnancy and Postpartum earns
its important place in the literature by detailing our current
understanding of the course, diagnosis, and treatment of
psychiatric illness during pregnancy and postpartum, including
breast-feeding -- a top priority today because we now know that
active maternal psychiatric illness during pregnancy and postpartum
can exert long-term negative effects on child development and cause
significant morbidity for the mother.
In just five concise richly informative chapters, the nine
distinguished contributors to Mood and Anxiety Disorders During
Pregnancy and Postpartum dispel prevailing beliefs and offer
invaluable guidance in treating women during pregnancy and
postpartum: - Course of Psychiatric Illness During Pregnancy and
the Postpartum Period -- Despite the enduring belief that pregnancy
is a time of emotional well-being for women, emerging data show
that pregnancy is instead a time of increased vulnerability to
psychiatric illness.- Diagnosis and Treatment of Mood and Anxiety
Disorders During Pregnancy -- Though the use of psychotropic
medications during pregnancy and postpartum raises concerns, the
accumulating data support the use of certain SSRIs/tricyclic
antidepressants, especially when balanced against the risk to both
mother and child of depression during pregnancy.- Management of
Bipolar Disorder During Pregnancy and the Postpartum Period:
Weighing the Risks and Benefits -- Although the onset of bipolar
disorder (BP) tends to occur during women's reproductive years,
surprisingly little is known about the impact of the menstrual
cycle, pregnancy, postpartum, breast-feeding, and menopause on the
course and treatment of bipolar disorder. - Postpartum Mood
Disorders -- Women experience a dramatic increase in their risk of
developing severe psychiatric illness during postpartum for a full
year after delivery. Often overlooked, postpartum disorders must be
identified and treated as early as possible to reduce the mother's
risk for recurrent and treatment-refractory illness and the child's
risk for long-term development problems due to the detrimental
effect of maternal depression.- Use of Antidepressants and Mood
Stabilizers in Breast-feeding Women -- This expanded clinical
appraisal of the literature on antidepressant and mood stabilizer
use in breast-feeding women shows that additional detailed
pharmacokinetic investigations are urgently needed to enhance our
understanding of nursing infant exposure and the role(s) of
pharmacogenomics in determining infant exposure.
Meticulously referenced and remarkably succinct, Mood and
Anxiety Disorders During Pregnancy and Postpartum provides critical
information about the course of illness during pregnancy and
postpartum to help guide effective individualized treatment
decisions-decisions that are ultimately based on the patient's
wishes.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!